The Moopen family, promoters of Aster DM Healthcare, have raised their stake in the India-listed company by 4%, from 37.88% to 41.88%. They achieved this expansion by acquiring additional shares worth Rs 460 Crore (Dh. 207 million) from a prominent private equity investor.
Dr. Azad Moopen, the Founder Chairman and Managing Director, emphasized the family’s commitment to the business, its patients, and employees. Aster DM Healthcare, with a revenue of Rs. 10,253 crore in FY 2021-22, is experiencing significant growth due to restructuring efforts in India and GCC.
The company has numerous upcoming projects in India, including new hospitals in Trivandrum, Kasargod, Tirupati, and Mandya. Additionally, 239 Aster pharmacies and 177 Aster Labs & patient experience centers have been launched. With 4,095 beds in 15 Indian hospitals and plans to increase to 4,670 beds in 18 hospitals next fiscal year, Aster will connect all facilities through the forthcoming myAster App, offering omnichannel care to customers.
Aster DM Healthcare is expanding its presence in GCC with the opening of the 181-bed Aster Royal Hospital in Oman, the 101-bed Aster Hospital in Sharjah, and the acquisition of a 126-bed hospital in Al Qusais, which will be operational soon. This will establish Aster as one of the largest healthcare providers in the region, with 15 hospitals, 113 clinics, and 257 pharmacies. The company is also planning to roll out 250 new Aster Pharmacies in Saudi Arabia. The myAster App, which has already seen 352,000+ downloads since its launch, will integrate the omnichannel healthcare delivery system.